Introduction
A central event in the pathogenesis of tissue ®brosis is the activation of resident perivascular mesenchymal cells which proliferate and produce extracellular matrix in response to injury. In the liver, the hepatic stellate cell ful®ls this role (Friedman, 1993b) . These perisinusoidal vitamin A-storing cells are widely distributed throughout the normal liver, and transform during injury into a ®brogenic cell (Friedman et al., 1985; Gressner, 1995) which is proliferative (Geerts et al., 1991) and contractile (Kawada et al., 1992; Rockey et al., 1993) . Stellate cell activation is a phenotypic transition which is similar regardless of the type of liver injury, and which re¯ects a cascade of gene induction comprising both regulatory and structural components (Friedman, 1996) .
An important role in stellate cell activation has emerged for receptor tyrosine kinases (RTKs), signaling molecules which underlie cell growth and differentiation in all tissues. Many of the phenotypic features of stellate cell activation are mediated by signaling through RTKs. For example, stellate cell proliferation in culture and in vivo is preceded by rapid induction of the b subunit of platelet derived growth factor receptor (PDGFR) . Similarly, basic ®broblast growth factor (bFGF), another RTK ligand, is produced by and stimulates proliferation of stellate cells (Hioki et al., 1996; Rosenbaum et al., 1995) . FGF receptors have been identi®ed on stellate cells, and bFGF also mediates the mitogenic eect of transforming growth factor b1 (TGFb1) in activated human stellate cells (Rosenbaum et al., 1995) . In vivo, FGF may stimulate extracellular matrix production and vascularization following liver injury by both autorcrine and paracrine mechanisms (Hioki et al., 1996) .
The general organization of RTKs is well established. All RTKs are composed of three major domains: a highly conserved cytoplasmic tyrosine kinase domain, comprising about 200 ± 300 amino acids (Hanks et al., 1988) , a single transmembrane spanning domain and a highly diverse extracellular region (reviewed in Fantl et al., 1993) . Binding by ligands elicits a diverse range of cellular responses depending on the cell-type and the speci®c RTK (Schlessinger, 1993) . Responsiveness of cells to RTK ligands may also be regulated by extracellular matrix (ECM), which can modulate RTK abundance or function (Xu and Clark, 1996) . Because changes in ECM composition are a major component of liver injury, it is possible that one consequence of ®brosis may be altered RTK expression and/or signaling.
Given the importance of RTKs to wound healing in liver, in this study we exploited the technique of homology PCR to clone RTKs expressed during stellate cell activation in order to de®ne their role in liver injury, and as a model for how RTKs might contribute to tissue repair in other organs. Because this approach yielded the unexpected ®nding of receptors for vascular endothelial growth factor (VEGF) in stellate cells, we have speci®cally explored the potential role of VEGF signaling in mediating features of stellate cell activation, and have compared their response to sinusoidal endothelial cells, the other mesenchymal cell type of the hepatic sinusoid.
Results

Homology PCR cloning of RTKs in activated stellate cells
To identify cDNAs expressed during activation of stellate cells, homology cloning was performed according to the strategy of Raz et al. (1991) . The template was a rat stellate cell activation-induced cDNA library derived by subtraction cloning from stellate cells isolated 3 h after a single dose of intragastric CCL 4 (Lalazar et al., 1997) . The PCR cloning strategy yielded 64 clones representing six dierent RTK genes, all containing the expected *200 bp insert (see Table 1 ). These included receptors for vascular endothelial growth factor, hepatocyte growth factor, platelet derived growth factor, and an orphan receptor (Tie-1). Tie-1 is expressed on human hematopoietic progenitor cells, endothelial cells and megakaryocytes (Batard et al., 1996; Rodewald and Sato, 1996) and plays an important role in vasculogenesis (Dumont et al., 1993; Sato et al., 1995) . In addition to these known RTKs. a novel RTK, clone`RTK40' (Genbank Accession no. AF016247), was recovered whose tyrosine kinase sequence assigns it to a new subfamily which have a lectin-like domain in their extracellular regions (other members include Tyro 10/DDR2) Lai and Lemke, 1994) .
Characterization of 125 I VEGF binding sites in stellate cells
The cloning of VEGF receptor cDNAs from stellate cells was surprising given its presumed restriction to endothelial cells. To con®rm expression of¯k-1 and¯t-1 mRNA by stellate cells we analysed their expression in pure cell isolates after activation in vivo by administration of CCl 4 . There was biphasic expression of the two VEGF receptors in stellate cells during injury:¯t-1 mRNA was modestly induced beginning 3 h after CCl 4 (Figure 1 ) whereas¯k-1 mRNA was down-regulated initially. However, both transcripts were markedly induced in vivo beginning 96 h after a single dose of CCl 4 . This time course of induction diers from that of the b-PDGF receptor which is induced within 1 h under identical conditions .
To further characterize VEGF binding sites on stellate cells, saturation binding studies were performed and compared to those of sinusoidal endothelial cells, which are known to express receptors for VEGF (Yamane et al., 1994 (Table 2) .
VEGF activity and eect of extracellular matrix in cultured stellate cells
We and others (Friedman et al., 1989; Davis, 1988) have previously demonstrated that the composition of the extracellular matrix determines whether stellate cells will activate in primary culture. Modulation of VEGF binding during stellate cell activation was explored by allowing the cells to activate through growth on type I collagen, an established model of culture activation (Friedman et al., 1989) . Table 2 .
Whereas cells plated on either uncoated plastic or type I collagen activate progressively, those on a basement membrane substratum resembling the normal subendoethelial matrix of liver (EHS matrix) remain quiescent (Friedman et al., 1989) . Mitogenesis of HSCs increased 2.5-fold in response to VEGF (50 ng/ml) after 10 days in culture on plastic, and was augmented by co-incubation with basic ®broblast growth factor (bFGF), a cytokine with known synergy with VEGF ( Figure 4 ). VEGF-induced proliferation was more prominent in SECs than in stellate cells: there was an eightfold increase in [ on collagen I, whereas cells grown on basement membrane-like matrix (EHS) were nonproliferative. VEGF and bFGF were also synergistically mitogenic in SECs, as in HSCs (data not shown).
Discussion
The current study has addressed the potential role of RTKs in the phenotype of activated stellate cells, the liver's principal ®brogenic element. By utilizing homology PCR we have successfully identi®ed several RTK transcripts expressed during stellate cell activation, including those of receptors for VEGF (Flk-1 and Flt-1), HGF, PDGF, as well as an RTK (`RTK40') with homology to a new subfamily of receptors containing lectin-like domains, as exempli®ed by Tyro 10 (Lai and Lemke, 1994) . Our strategy has uncovered low-abundance RTK transcripts whose expression may have previously been ascribed only to other cell types. Given PCR's sensitivity, however, it was essential to con®rm that the RTKs identi®ed were truly expressed in stellate cells, as we have done for¯k-1 and¯t-1, and RTK40 (not shown). A recent report (Ikeda et al., 1996) further validates our approach by also identifying c-met mRNA in stellate cells, which in liver had been previously thought to be con®ned to hepatocytes.
The liver's response to injury can be viewed as an angiogenic one, with new blood vessel formation, proliferation of mesenchymal elements and extracellular matrix deposition as prominent features. Signaling by the RTK for vascular endothelial growth factor (VEGF) is a critical component of angiogenesis in other tissues, but has not been studied in liver injury. At least two major vascular endothelial growth factor receptors (VEGFRs) have been cloned and characterized: Flk-1 (Fetal liver kinase 1) and Flt-1 (Fms-like kinase 1) (de Vries et al., 1992; Mustonen and Alitalo, 1995; Quinn et al., 1993; Terman et al., 1992) . One report (Yamane et al., 1994) has suggested that VEGF is proliferative toward cultured sinusoidal endothelial cells, but the importance of VEGF to either stellate cells in culture or in vivo, or sinusoidal endothelial cell behavior in vivo has not been explored.
The identi®cation of VEGF receptors¯k-1 and¯t-1 in stellate cells, combined with earlier studies documenting VEGF expression in hepatocytes (Mochida et al., 1996; Suzuki et al., 1996) , establishes the components of a potential paracrine loop between hepatocytes and stellate cells. After the onset of liver injury due to CCl 4 there is an early, modest induction of¯t-1 mRNA in stellate cells; in contrast,¯k-1 mRNA is slightly downregulated, then both transcripts are markedly induced at a later interval (96 h). This pattern of expression in stellate cells is distinct from b-PDGF receptor mRNA, which is rapidly induced within 1 h . The dierent behavior of¯t-1/¯k-1 mRNAS compared to b-PDGF receptor underscores the concept that stellate cell activation comprises a programmed, sequential cascade of gene expression rather than a generalized transformation where many genes are simultaneously induced. Moreover, it suggests that angiogenic responses mediated by VEGF may persist beyond the phase of acute tissue repair, since much of the toxic damage is repaired at this later interval. Regardless, it is clear that signaling associated with VEGF in wound healing extends to cell types apart from endothelial cells. Indeed,¯t-1 has recently been detected in capillary pericytes (Nomura et al., 1995) and mesangial cells (Takahashi et al., 1995) , cell types which are functionally equivalent to stellate cells.
In addition to its role in tissue repair, angiogenesis is also critical to tumor formation. The recognition that hepatic stellate cells respond to angiogenic stimuli could imply a potential role for this cell type in tumor growth, since activated stellate cells have been identi®ed in the stroma of human liver tumors (Enzan et al., 1994) . Moreover, upregulation of VEGF and bFGF mRNAs have been documented in primary (Mise et al., 1996; Suzuki et al., 1996) and experimental metastatic liver tumors (Warren et al., 1995) .
In this study as in our previous work, culture models of activation were used to complement in vivo ®ndings. Associated with culture-induced activation is a marked increase in VEGF binding sites and receptor on stellate cells without signi®cantly altering anity, suggesting that receptor number may correlate with stellate cell activation. We have previously documented a similar response in stellate cells for TGFb1 receptors .
What are the implications of VEGF acting on stellate cells? This issue can be addressed by reviewing the known pleiotropic actions of VEGF associated with angiogenesis. These activites include increased cell proliferation, vascular permeability, migration and protease expression (Connolly et al., 1989; Leung et al., 1989) . Proliferation has been documented in this study. While it is unclear how VEGF could alter sinusoidal permeability via eects on stellate cells, a role in regulating protease release is quite plausible. For example, VEGF induces the expression of serine proteases urokinase-type and tissue-type plasminogen activators (PA) and also PA inhibitor-1 (PAI-1) in cultured bovine microvascular endothelial cells and these components of the plasminogen system have also been identi®ed in stellate cells (Pepper et al., 1991) . Furthermore, VEGF induces the expression of the Figure 4 Matrix dependency of VEGF induced hepatic stellate cell proliferation. Stellate cells were grown on either collagen type I or basement membrane-like EHS matrix for 6 days in the presence of 20% FCS, serum starved for 48 h, and then treated with VEGF with or without bFGF for 48 h (without serum), followed by measurement of [ 3 H]thymidine incorporation. Data represent the mean of two experiments, each performed in triplicate and expressed as percent of control cells without added VEGF; standard error of the mean was less than 10% metalloproteinase interstitial collagenase in human umbilical vein endothelial cells, a function also ascribed to stellate cells (Unemori et al., 1992) . Thus, our ®nding of VEGF responsiveness in stellate cells points to a similar role in pericytes and related tissue myo®broblasts, an issue not previously explored.
Another novel aspect of our work was the demonstration that responsiveness to VEGF in stellate cells was activation-dependent, which in turn is in¯uenced by the extracellular matrix. This observation has direct relevance to matrix remodeling during liver injury and wound healing. In exploring this issue we utilized two dierent matrices which model the normal and injured liver, respectively: EHS matrix, which mimics the subendothelial basement-membrane matrix and maintains resident sinusoidal cells in a dierentiated state (Friedman et al., 1989) ; and collagen I, which predominates in the`injury' milieu of the damaged liver. The increased responsiveness to VEGF during prolonged culture likely re¯ects, at least in part, the eects of a changing microenvironment on cell activation. Similar ®ndings are now emerging in related cell types. In microvascular endothelial cells for example, the eect of TFGb1 on cell proliferation is matrix-dependent (Sankar et al., 1996) .
The synergy of VEGF by bFGF in stellate cells on collagen I is also compatible with recent insights into how extracellular matrix can modulate cell function. bFGF is normally sequestered by the ECM, and during injury it is released available to the adjoining cells (Levi et al., 1996; Vlodavsky et al., 1996) . Thus, matrix degradation in liver may present additional bFGF to stellate and endothelial cells coincident with increased responsiveness via VEGF receptor induction. Since stellate cells are the primary source of bFGF during liver injury (Hioki et al., 1996) an autocrine loop for bFGF activity may be established during liver injury. Moreover, VEGF is known to increase production of bFGF (Stavri et al., 1995) . Collectively, these ®ndings suggest stellate cell mitogenesis likely results from both autocrine and paracrine interactions.
In summary, our ®ndings demonstrate for the ®rst time that VEGF receptors are induced during stellate cell activation and that reponsiveness to VEGF is matrix-dependent. This observation points toward the possibility of neutralizing RTK activity as a therapy for hepatic ®brosis associated with injury or neoplasia.
Materials and methods
Isolation and primary culture of pure cell populations from normal and injured rat liver Hepatic stellate cells were isolated from retired breeder Sprague-Dawley rats (450 ± 600 g) by in situ portal vein perfusion with pronase and collagenase, followed by density gradient centrifugation with arabinogalactan (Friedman, 1993a) . Sinusoidal endothelial cells (SECs) were further puri®ed from the lower layers of the density gradient by centrifugal elutriation (Jarnagin et al., 1994) . All cells were cultured on plastic dishes in the presence of 20% serum (10% calf : 10% horse). For experiments requiring the isolation of cells from injured liver, animals were administered 0.5 ml carbon tetrachloride (CCl 4 ) per gram body weight by gavage, as described by Proctor (Proctor and Chatamra, 1982) . Cells from these animals were isolated using the same method as for normals, as previously described . Stellate cells maintained in culture were grown on either uncoated plastic, on plastic coated with a collagen I or a basement membrane-like substratum (`EHS matrix') as previously described (Friedman et al., 1989) . mRNA analysis/RNAse protection assay Total RNA was isolated from cell pellets by using Trireagent (MRC) according to manufacturer's recommendations. Aliquots of total RNA were incubated with 0.5 ± 1.0610 6 Cerenkov c.p.m. of labeled probe, denatured at 788C, and hybridized in solution at 558C overnight, for all probes as previously described; hybridization to the ribosomal S14 mRNA was used as an internal standard (Maher and McGuire, 1990) . The RNA/probe complexes were digested with T2 RNAse for 60 min at 308C, and the protected probes denatured and resolved on a 5% polyacrylamide sequencing gel. The gel was dried and exposed overnight to X-ray ®lm, and speci®c bands were quantitated by densitometry. Each assay included a sample of probe incubated with yeast tRNA as a negative control.
DNA sequencing and analysis
Sequencing was performed by the UCSF Biomolecular Resource Center using a Taq polymerase based system and an automated sequencer by Applied BioSciences. cDNA inserts in pGEM4 vector in water were used for sequencing from the SP6 and T7 polymerase sites. For high quality sequencing prior to data entry into GenBank we con®rmed the automated sequence using a commercial kit according to manufacturer's speci®cations (Sequenase 2.0, US Biochemical). Dried gels were exposed overnight to X-ray ®lm and manually read. The GenBank FASTA program was used for homology searches.
Polymerase chain reaction
For reverse transcriptase PCR (RT ± PCR), ®rst strand cDNA was generated with avian myeloblastosis virus reverse transcriptase using 2 mg mRNA and oligo-dT primer (Gibco BRL). This template cDNA was incubated with Taq polymerase in the presence of 5 mM nucleotides, magnesium-containing reaction buer (2 mM), and primers containing restriction sequences (XbaI and EcoRI) to facilitate subcloning of ampli®ed products. The regions of interest were ampli®ed for 30 cycles in a thermal cycler (Ericomp) with annealing temperatures ranging from 42 ± 588C, determined empirically, and extension time from 1 ± 3 min. Ampli®ed products were visualized on a 1 ± 1.5% low-melt agarose gel and the excised bands of interest puri®ed using a commercial kit (Promega Magic PCR). All experiments contained a negative control in which template was omitted. Positive control template DNA (i.e., known to contain the sequence of interest) were included as appropriate.
Homology PCR of receptor tyrosine kinases (RTKs) induced during stellate cell activation in vivo Activation-induced genes in stellate cells were isolated by subtraction cloning from cells activated in vivo by intragastric administration of CCl 4 as previously described (Lalazar et al., 1997) . In brief, cDNA libraries were constructed from both freshly isolated stellate cells from normal rats (i.e. quiescent cells) and from rats treated 3 h earlier with the hepatotoxin CCl 4 (i.e.`activated cells'). mRNA was extracted directly from quiescent and activated stellate cells using a commercial kit (Invitrogen). Following biotinylation of the quiescent stellate cells-cDNA library and the addition of linkers speci®c for each population, the two cDNA populations were exhaustively hybridized to one another. Duplexes containing quiescent-speci®c cDNAs were removed by binding to streptavidin, and activation-speci®c (i.e. unhybridized) cDNAs were selectively ampli®ed by polymerase chain reaction. The activation-speci®c clones were packaged using a commercial packaging mix (Packagene) and transfected into LE 392 bacteria; packaging eciency was calculated at *7610 6 p.f.u. per mg of DNA insert. Using this activation-speci®c cDNA library as template, PCR was performed with RTK-speci®c primers based on a 200 bp region within the tyrosine kinase domain which is conserved in the RTK superfamily. Primers were derived from domains VI and IX of tyrosine kinases (Hanks et al., 1988) and were nearly identical to those previously described by Raz et al. (1991) , but with slightly more codon degeneracy and dierent restriction sites (XbaI/EcoRI). The sequences of primers used were: (i) TK6 ( Ampli®cation conditions were identical to those described by Raz et al. (1991) employing 35 cycles with 3 min elongation at 658C. The PCR products were puri®ed using a commercial kit (Promega Magic PCR), directionally cloned into pGEM-4 at XbaI/EcoRI sites and used to transform competent JM 109 bacteria. After overnight growth, 5 ml liquid cultures were inoculated with individual colonies, from which DNA was puri®ed using a commercial kit (Promega Miniprep). Inserts were identi®ed by restriction with XbaI/ EcoRI and sequenced as described.
Saturation binding assay
Binding assays for VEGF were performed as previously described (Myoken et al., 1991) . Puri®ed VEGF was iodinated to a speci®c activity of 156 Ci/g, (1.78610 78 M) using Iodogen beads. Cells were seeded at 2.5610 4 cells/ well in 24-well tissue culture plates and allowed to grow for 1, 4 and 10 days. The cells were washed with 0.5 ml of binding medium (Hanks' BSS containing 1% bovine serum albumin, 25 mM HEPES (pH 7.4)) and then incubated in 0.5 ml binding medium containing [
125 I]VEGF for 6 h at 48C. After two washes in binding medium, the cells were solubilized with 0.5 ml of 0.1 M NaOH. Triplicate samples of each condition were obtained for each experiment. Nonspeci®c binding was determined in the presence of a 500-fold molar excess of unlabeled VEGF to the binding medium of parallel cultures and was subtracted from all samples. The soluble lysates were counted in a gamma counter. The data were analysed as described by Mori et al. (1991) . The number of cells/well was assessed by trypinization and direct counting of duplicate wells.
Western blot
Stellate cells in primary culture for the indicated intervals were harvested in lysis buer (20 mM Tris-HCl, pH 7.9; 1% Triton X-100, 137 mN NaCl; 10% glycerol; 1 mM PMSF; 1 mg/ml aprotinin; 1 mg/ml leupeptin) and the protein content was determined by commercial assay (Coomassie Plus protein assay reagent, Pierce Chemical, Rockford, IL). For Flt-1, 20 mg protein per lane was separated on 6% SDS ± PAGE under reducing conditions, transferred to nitrocellulose and incubated overnight at 48c in TBS-Tween containing a polyclonal antibody to human Flt-1 (1 : 1000) (Santa Cruz Biotechnology, catalog #sc-316). Western blot for Flk-1 was performed in separate stellate cell isolates at the same plating intervals, using 10 mg protein per lane (1 : 500) (Santa Cruz Biotechnology, catalog #sc-504). Following three washes, the blots were incubated in secondary antibody, anti-rabbit Ig-HRP-linked whole antibody from donkey (1 : 1000) (Amersham) for 1 h at room temperature, and proteins visualized using a commercial chemiluminiscence kit (SuperSignal chemiluminescent substrate, Pierce Chemical).
Cell proliferation
To measure cell proliferation, DNA replication was measured by [
3 H]thymidine incorporation as previously described (Friedman et al., 1989) . Brie¯y, cells were seeded in triplicate wells at a density of 2610 4 cells/well of an uncoated 24-well dish in standard growth medium and cultured at 378C. After 6 ± 10 days of incubation, cells were serum starved for 48 h and then received recombinant VEGF (0 ± 100 ng/ml) (a gift from Dr N Ferrara, Genentech) or 20% FCS for an additional 72 h. Note added in proof Two recent reports have identi®ed triple-helical collagens as ligands for the DDR receptors (Shrivastava et al., 1997; Vogel et al., 1997) .
